Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C24H26N2OS2 |
Molecular Weight | 422.606 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12CCC3=CC(SC4=NC5=C(CC)C=CC=C5S4)=CC=C3[C@@]1(C)CCC(=O)N2C
InChI
InChIKey=VMGWGDPZHXPFTC-HYBUGGRVSA-N
InChI=1S/C24H26N2OS2/c1-4-15-6-5-7-19-22(15)25-23(29-19)28-17-9-10-18-16(14-17)8-11-20-24(18,2)13-12-21(27)26(20)3/h5-7,9-10,14,20H,4,8,11-13H2,1-3H3/t20-,24-/m1/s1
Molecular Formula | C24H26N2OS2 |
Molecular Weight | 422.606 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
IZONSTERIDE, a benzoquinolinone, is a selective inhibitor of the 5-alpha reductase, with antagonistic effect on both the type I (liver, skin, hair follicles) and type II (prostate) isoforms of the enzyme. It is a competitive inhibitor of type I 5-alpha reductase and a non-competitive inhibitor of type II 5-alpha reductase. It was under development for the treatment of prostatic cancer.
Originator
Approval Year
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/10731633
IZONSTERIDE inhibits 5-alpha reductase activity in human scalp skin (Ki=28.7+/-1.87 nM) and prostatic homogenates (Ki=10.6+/-4.5 nM).
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:39:14 GMT 2023
by
admin
on
Fri Dec 15 15:39:14 GMT 2023
|
Record UNII |
A5E8C36F34
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C2319
Created by
admin on Fri Dec 15 15:39:14 GMT 2023 , Edited by admin on Fri Dec 15 15:39:14 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID80170230
Created by
admin on Fri Dec 15 15:39:14 GMT 2023 , Edited by admin on Fri Dec 15 15:39:14 GMT 2023
|
PRIMARY | |||
|
172988
Created by
admin on Fri Dec 15 15:39:14 GMT 2023 , Edited by admin on Fri Dec 15 15:39:14 GMT 2023
|
PRIMARY | |||
|
176975-26-1
Created by
admin on Fri Dec 15 15:39:14 GMT 2023 , Edited by admin on Fri Dec 15 15:39:14 GMT 2023
|
PRIMARY | |||
|
C407322
Created by
admin on Fri Dec 15 15:39:14 GMT 2023 , Edited by admin on Fri Dec 15 15:39:14 GMT 2023
|
PRIMARY | |||
|
7848
Created by
admin on Fri Dec 15 15:39:14 GMT 2023 , Edited by admin on Fri Dec 15 15:39:14 GMT 2023
|
PRIMARY | |||
|
C99548
Created by
admin on Fri Dec 15 15:39:14 GMT 2023 , Edited by admin on Fri Dec 15 15:39:14 GMT 2023
|
PRIMARY | |||
|
A5E8C36F34
Created by
admin on Fri Dec 15 15:39:14 GMT 2023 , Edited by admin on Fri Dec 15 15:39:14 GMT 2023
|
PRIMARY | |||
|
Izonsteride
Created by
admin on Fri Dec 15 15:39:14 GMT 2023 , Edited by admin on Fri Dec 15 15:39:14 GMT 2023
|
PRIMARY | |||
|
CHEMBL2104854
Created by
admin on Fri Dec 15 15:39:14 GMT 2023 , Edited by admin on Fri Dec 15 15:39:14 GMT 2023
|
PRIMARY | |||
|
300000034299
Created by
admin on Fri Dec 15 15:39:14 GMT 2023 , Edited by admin on Fri Dec 15 15:39:14 GMT 2023
|
PRIMARY | |||
|
KK-57
Created by
admin on Fri Dec 15 15:39:14 GMT 2023 , Edited by admin on Fri Dec 15 15:39:14 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
|
||
|
TARGET -> INHIBITOR |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|